Pharming Group N.V. provided earnings guidance for the year 2024. For the year, the company expects total revenue between $280 million and $295 million.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8845 EUR | -1.17% | -1.50% | -14.21% |
07:00am | Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 22 | Pharming Group to Buy Back EUR123 Million of Bonds due 2025 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.21% | 650M | |
+33.43% | 700B | |
+27.65% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.21% | 236B | |
+6.52% | 202B | |
-9.24% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Group N.V. Provides Earnings Guidance for the Year 2024